SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001610717-24-000176
Filing Date
2024-03-21
Accepted
2024-03-21 16:37:36
Documents
1
Period of Report
2024-03-19

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3231
  Complete submission text file 0001610717-24-000176.txt   4724
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Issuer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CYTOMX THERAPEUTICS, INC. 151 OYSTER POINT BLVD., STE. 400 SOUTH SAN FRANCISCO CA 94080
Business Address
BELVIN MARCIA (Reporting) CIK: 0001970752 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37587 | Film No.: 24771913